Jinling Pharmaceutical Co.,Ltd.’s Net Profit Rose 4.4% in First Quarter of 2022

Jinling Pharmaceutical Co.,Ltd. (金陵药业股份有限公司) (000919.SZ) reported a net profit of 44.4 million yuan in the first quarter of 2022, up 4.4% year-on-year.

Meanwhile, the company posted 693 million yuan in revenue, down 1.2% year-on-year.

At the end of the reporting period, it had 4.4 billion yuan in total assets and 837.7 million yuan in total liabilities, with a liability-to-asset ratio of 18.9%.